Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
ZIOPHARM ONCOLOGY Add to My Watchlist (NSDQ: ZIOP) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     ZIOPHARM 3.09 +0.01 (+0.32%) 57,291
1180 Avenue of the Americas
19th Floor
New York, NY 10036 US
(646) 214-0700
(646) 214-0711 fax
www.ziopharm.com
CEO Dr. Jonathan Lewis, M.D., Ph.D.
Auditor Vitale, Caturano & Company, P.C.
Exchange Traded NQ
ISIN Number US98973P1012
CIK Number 1107421
NAICS Code 325412
Business Summary
A biopharmaceutical company that is seeking to develop and commercialize a diverse, risk-sensitive portfolio of in-licensed cancer drugs that address unmet medical needs.
Number of Employees 17
Share Fundamentals
Market Cap 79.02M
Shares Outstanding 25.57M
Float 20.59M
Short Interest 299.08K
Financial Strength
Revenue (TTM) N/A
Earnings (TTM) -$13,176,000
Quick Ratio 2:1
Current Ratio 2.1:1
Total Debt/Equity 0:1
Profitability
Gross Margin N/A
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Daily Market Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs